4Sulivan BL,Leu D,Taylor DM,et al.Isoflurane prevents delayed cell death in an organotypic slice culture model of cerebral ischemia[J].Anesthesiology,2002;96(1):189-95.
5Wilson JX,Gelb AW.Free radicals,antioxidants,and neurologic injury:possible relationship to cerebral protection by anesthetics[J].Neurosurg Anesthesiol,2002;14(1):66-79.
2Cudkowicz ME. Epidemiology of mutation in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997;41:210-21.
3Browne SE,Bowling, AC,Baik MJ, et al. Metabolic dysfunction in familial,but not sporadic, amyotrophic lateral sclerosis. J Neurochem 1998;71(1):281-7.
4Wiedau-Pazos M. Altered reactivity of superoxide dismutase in familiar amyotrophic lateral sclerosis. Science 1996;271:515-8.
5Bruijn LI.Aggregation and motor neuron toxicity of an ALS-liked SOD1mutant independent from wild-type SOD1. Science 1998;281:1851-4.
6Cookson MR,Menzies FM,Manning P,et al. Cu/Zn superoxide dismutase(SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS)affect cellular free radical release in the presence of oxidative stress.Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3(2):75-85.
7Grazyna K,Peter J.The distribution of copper, zinc- and manganesesuperoxide dismutase, and glutathione peroxidase messenger ri1bonucleic acid in rat basal ganglia. Biochem Pharmacol 2002;63(6):1159-64.
8Bandmann O,Davis MB,Marsden CD, et al. Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1995; 59(1):90-1.
9Figlewicz DA,Garruto R M,Krizus A, et al. The Cu/Zn superoxide dismutase gene in ALS and parkinsonism-dementia of Guam. Neuroreport 1994; (55):557-60.
10Shimoda-Matsubayashi S,Hattori T, Matsumine H, et al. Mn SOD activity and protein in a patient with chromosome 6-1inked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology 1997;49(5):1257-62.
